Aurobindo Pharma announced the completion of acquisition of assets of nutritional supplement maker, Natrol Inc. and other affiliate entities (Natrol) through its wholly owned subsidiary Aurobindo Pharma US Inc (APUSA). APUSA emerged as the highest and best bidder to acquire assets of Natrol under the auction process by the US bankruptcy court for the district of Delaware.
APUSA acquired the Natrol’s manufacturing assets, personnel, and commercial infrastructure including the nutraceuticals brands in the US along with an agreement to take on certain liabilities, with a bid of $132.5 million. The assets have been acquired under a wholly owned subsidiary, Nature Acquisition LLC and since changed to Natrol LLC. APUSA expects the profitability to improve by combining the strength of both enterprises in creating a fully integrated nutraceuticals platform in the US and other international markets.
Mesrop Khoudagoulian, Natrol Chief Executive Officer commented, “I am pleased that Aurobindo recognises the values of Natrol’s uncompromised quality products, loyal customers, talented employees and solid relationships with our retailer partners. We look forward to working with the Aurobindo team to further expand our over-the-counter product portfolio and our reach with the financial support of strong owners.”
N Govindarajan, Managing Director, Aurobindo stated, “Natrol comes with certain well established brands and an extensive distribution network consisting of retail pharmacy chains and specialty health food stores, to help us tactically position ourselves in the US nutraceuticals space and offer an effective growth strategy to expand market penetration going forward.’
EP News Bureau – Mumbai